 |
 |
 |
|
 | |||||
| |||||||||
 | |||||||||
|
|
 |
|
|
Prescription and Over-the-Counter Drug Product List Prescription OTCNOTE: The format for the Monthly Additions/Deletions Drug
Product List changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.6
Cumulative Supplement Legend. ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE
SOLUTION; INHALATION
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
>A> AN APOTEX CORP EQ 0.083% BASE;0.017% N77117 001 Dec 31, 2007 Dec NEWA
>A> AN BREATH LTD EQ 0.083% BASE;0.017% N77063 001 Dec 31, 2007 Dec NEWA
>A> AN IVAX PHARMS INC EQ 0.083% BASE;0.017% N76724 001 Dec 31, 2007 Dec NEWA
>A> AN NEPHRON EQ 0.083% BASE;0.017% N76749 001 Dec 31, 2007 Dec NEWA
>A> AN WATSON LABS EQ 0.083% BASE;0.017% N77559 001 Dec 31, 2007 Dec NEWA
BALSALAZIDE DISODIUM
CAPSULE; ORAL
>A> BALSALAZIDE DISODIUM
>A> AB APOTEX INC 750MG N77883 001 Dec 28, 2007 Dec NEWA
>A> AB MYLAN 750MG N77807 001 Dec 28, 2007 Dec NEWA
>A> AB ROXANE 750MG N77806 001 Dec 28, 2007 Dec NEWA
COLAZAL
>D> + SALIX PHARMS 750MG N20610 001 Jul 18, 2000 Dec CFTG
>A> AB + 750MG N20610 001 Jul 18, 2000 Dec CFTG
BLEOMYCIN SULFATE
INJECTABLE; INJECTION
BLEOMYCIN
>A> AP PHARMACHEMIE BV EQ 15 UNITS BASE/VIAL N65201 001 Dec 13, 2007 Dec NEWA
BUPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
SENSORCAINE
>D> AP ABRAXIS 0.25% N18304 001 Dec CAHN
>D> AP 0.5% N18304 002 Dec CAHN
>D> AP 0.75% N18304 003 Dec CAHN
>A> AP APP PHARMS 0.25% N18304 001 Dec CAHN
>A> AP 0.5% N18304 002 Dec CAHN
>A> AP 0.75% N18304 003 Dec CAHN
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
INJECTABLE; INJECTION
SENSORCAINE
>D> AP ABRAXIS 0.5%;0.0091MG/ML N18304 004 Sep 02, 1983 Dec CAHN
>D> AP 0.75%;0.0091MG/ML N18304 005 Sep 02, 1983 Dec CAHN
>A> AP APP PHARMS 0.5%;0.0091MG/ML N18304 004 Sep 02, 1983 Dec CAHN
>A> AP 0.75%;0.0091MG/ML N18304 005 Sep 02, 1983 Dec CAHN
BUSPIRONE HYDROCHLORIDE
TABLET; ORAL
BUSPIRONE HYDROCHLORIDE
>A> AB ACTAVIS TOTOWA 30MG N78302 001 Dec 17, 2007 Dec NEWA
CARBOPLATIN
INJECTABLE; IV (INFUSION)
CARBOPLATIN
>A> AP + PHARMACHEMIE EQ 600MG/60ML (10MG/ML) N77269 004 Dec 28, 2007 Dec CRLD
CEFDINIR
CAPSULE; ORAL
CEFDINIR
>A> AB AUROBINDO 300MG N65434 001 Jan 07, 2008 Dec NEWA
FOR SUSPENSION; ORAL
CEFDINIR
>A> AB AUROBINDO 125MG/5ML N65473 001 Dec 14, 2007 Dec NEWA
>A> AB 250MG/5ML N65473 002 Dec 14, 2007 Dec NEWA
CEFTRIAXONE
INJECTABLE; IM-IV
CEFTRIAXONE
>A> AP HIKMA EQ 250MG BASE/VIAL N65342 001 Jan 10, 2008 Dec NEWA
>A> AP EQ 500MG BASE/VIAL N65342 002 Jan 10, 2008 Dec NEWA
>A> AP EQ 1GM BASE/VIAL N65342 003 Jan 10, 2008 Dec NEWA
>A> AP EQ 2GM BASE/VIAL N65342 004 Jan 10, 2008 Dec NEWA
CEPHALEXIN
CAPSULE; ORAL
CEPHALEXIN
>D> AB APOTHECON EQ 250MG BASE N63063 001 Sep 29, 1989 Dec DISC
>A> @ EQ 250MG BASE N63063 001 Sep 29, 1989 Dec DISC
>D> AB EQ 500MG BASE N63063 002 Sep 29, 1989 Dec DISC
>A> @ EQ 500MG BASE N63063 002 Sep 29, 1989 Dec DISC
CHLOROPROCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
NESACAINE
>D> + ABRAXIS 1% N09435 001 Dec CAHN
>D> AP 2% N09435 002 Dec CAHN
>A> + APP PHARMS 1% N09435 001 Dec CAHN
>A> AP 2% N09435 002 Dec CAHN
NESACAINE-MPF
>D> @ ABRAXIS 2% N09435 003 Dec CAHN
>D> AP + 2% N09435 006 May 02, 1996 Dec CAHN
>D> @ 3% N09435 004 Dec CAHN
>D> AP + 3% N09435 007 May 02, 1996 Dec CAHN
>A> @ APP PHARMS 2% N09435 003 Dec CAHN
>A> AP + 2% N09435 006 May 02, 1996 Dec CAHN
>A> @ 3% N09435 004 Dec CAHN
>A> AP + 3% N09435 007 May 02, 1996 Dec CAHN
CICLESONIDE
SPRAY, METERED; NASAL
OMNARIS
>D> + ALTANA PHARMA 0.05MG/INH N22004 001 Oct 20, 2006 Dec CAHN
>A> + NYCOMED US 0.05MG/INH N22004 001 Oct 20, 2006 Dec CAHN
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
CIPROFLOXACIN EXTENDED RELEASE
>A> AB SANDOZ 212.6MG;EQ 287.5MG BASE N78712 001 Dec 11, 2007 Dec NEWA
DICLOFENAC SODIUM
SOLUTION/DROPS; OPHTHALMIC
>A> DICLOFENAC SODIUM
>A> AT BAUSCH AND LOMB 0.1% N78792 001 Dec 28, 2007 Dec NEWA
>A> AT NEXUS PHARMS 0.1% N78553 001 Dec 28, 2007 Dec NEWA
VOLTAREN
>D> + NOVARTIS 0.1% N20037 001 Mar 28, 1991 Dec CFTG
>A> AT + 0.1% N20037 001 Mar 28, 1991 Dec CFTG
DILTIAZEM HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
CARDIZEM CD
>D> AB3 BIOVAIL 120MG N20062 001 Aug 10, 1992 Dec CAHN
>A> AB3 120MG N20062 001 Aug 10, 1992 Dec CAHN
>D> AB3 180MG N20062 002 Dec 27, 1991 Dec CAHN
>A> AB3 180MG N20062 002 Dec 27, 1991 Dec CAHN
>D> AB3 240MG N20062 003 Dec 27, 1991 Dec CAHN
>A> AB3 240MG N20062 003 Dec 27, 1991 Dec CAHN
>D> AB3 300MG N20062 004 Dec 27, 1991 Dec CRLD
>A> AB3 + 300MG N20062 004 Dec 27, 1991 Dec CRLD
>D> BC + 360MG N20062 005 Aug 24, 1999 Dec CAHN
>A> BC + 360MG N20062 005 Aug 24, 1999 Dec CAHN
DILTIAZEM HYDROCHLORIDE
>D> AB3 BIOVAIL 120MG N20939 001 Jan 28, 2000 Dec DISC
>A> @ 120MG N20939 001 Jan 28, 2000 Dec DISC
>D> AB3 180MG N20939 002 Jan 28, 2000 Dec DISC
>A> @ 180MG N20939 002 Jan 28, 2000 Dec DISC
>D> AB3 240MG N20939 003 Jan 28, 2000 Dec DISC
>A> @ 240MG N20939 003 Jan 28, 2000 Dec DISC
>D> AB3 300MG N20939 004 Jan 28, 2000 Dec DISC
>A> @ 300MG N20939 004 Jan 28, 2000 Dec DISC
>A> @ 360MG N20939 005 Sep 14, 2001 Dec DISC
>A> @ 420MG N20939 006 Sep 14, 2001 Dec DISC
INJECTABLE; INJECTION
>D> CARDIZEM
>D> AP + BIOVAIL 100MG/VIAL N20792 001 Sep 05, 1997 Dec DISC
>A> @ 100MG/VIAL N20792 001 Sep 05, 1997 Dec DISC
DILTIAZEM HYDROCHLORIDE
>D> AP HOSPIRA 100MG/VIAL N75853 001 Dec 17, 2002 Dec CRLD
>A> + 100MG/VIAL N75853 001 Dec 17, 2002 Dec CRLD
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
XYLOCAINE W/ EPINEPHRINE
>D> AP + ABRAXIS 0.005MG/ML;0.5% N06488 012 Dec CAHN
>D> AP + 0.005MG/ML;1% N06488 018 Nov 13, 1986 Dec CAHN
>D> AP + 0.005MG/ML;1.5% N06488 017 Dec CAHN
>D> AP + 0.005MG/ML;2% N06488 019 Nov 13, 1986 Dec CAHN
>D> AP + 0.01MG/ML;1% N06488 004 Dec CAHN
>D> @ 0.01MG/ML;2% N06488 003 Dec CAHN
>D> @ 0.02MG/ML;2% N06488 005 Dec CAHN
>A> AP + APP PHARMS 0.005MG/ML;0.5% N06488 012 Dec CAHN
>A> AP + 0.005MG/ML;1% N06488 018 Nov 13, 1986 Dec CAHN
>A> AP + 0.005MG/ML;1.5% N06488 017 Dec CAHN
>A> AP + 0.005MG/ML;2% N06488 019 Nov 13, 1986 Dec CAHN
>A> AP + 0.01MG/ML;1% N06488 004 Dec CAHN
>A> @ 0.01MG/ML;2% N06488 003 Dec CAHN
>A> @ 0.02MG/ML;2% N06488 005 Dec CAHN
ETOPOSIDE
INJECTABLE; INJECTION
ETOPOSIDE
>A> AP ACCORD HLTHCARE 20MG/ML N74513 001 Mar 14, 1996 Dec CAHN
>D> AP SUPERGEN 20MG/ML N74513 001 Mar 14, 1996 Dec CAHN
FENOFIBRATE
TABLET; ORAL
TRIGLIDE
>D> BX SKYEPHARMA AG 160MG N21350 002 May 07, 2005 Dec CRLD
>A> BX + 160MG N21350 002 May 07, 2005 Dec CRLD
FLUVOXAMINE MALEATE
TABLET; ORAL
>A> LUVOX
>A> AB SOLVAY 25MG N21519 001 Dec 20, 2007 Dec NEWA
>A> AB 50MG N21519 002 Dec 20, 2007 Dec NEWA
>A> AB 100MG N21519 003 Dec 20, 2007 Dec NEWA
FOMEPIZOLE
INJECTABLE; INJECTION
ANTIZOL
>D> + JAZZ 1GM/ML N20696 001 Dec 04, 1997 Dec CFTG
>A> AP + 1.5GM/1.5ML (1GM/ML) N20696 001 Dec 04, 1997 Dec CFTG
>A> FOMEPIZOLE
>A> AP PHARMAFORCE 1.5GM/1.5ML (1GM/ML) N78368 001 Dec 14, 2007 Dec NEWA
GLIMEPIRIDE; ROSIGLITAZONE MALEATE
TABLET; ORAL
AVANDARYL
>A> SB PHARMCO 2MG;8MG N21700 004 Mar 30, 2007 Dec NEWA
>A> 4MG;8MG N21700 005 Mar 30, 2007 Dec NEWA
GONADOTROPIN, CHORIONIC
INJECTABLE; INJECTION
CHORIONIC GONADOTROPIN
>D> @ ABRAXIS PHARM 5,000 UNITS/VIAL N17067 001 Dec CAHN
>D> AP + 10,000 UNITS/VIAL N17067 002 Dec CAHN
>D> @ 15,000 UNITS/VIAL N17067 004 Dec CAHN
>D> @ 20,000 UNITS/VIAL N17067 003 Dec CAHN
>A> @ APP PHARMS 5,000 UNITS/VIAL N17067 001 Dec CAHN
>A> AP + 10,000 UNITS/VIAL N17067 002 Dec CAHN
>A> @ 15,000 UNITS/VIAL N17067 004 Dec CAHN
>A> @ 20,000 UNITS/VIAL N17067 003 Dec CAHN
GRANISETRON HYDROCHLORIDE
INJECTABLE; INJECTION
>A> GRANISETRON HYDROCHLORIDE
>A> AP APOTEX CORP EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) N78197 001 Dec 31, 2007 Dec NEWA
>A> AP APP PHARMS EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) N78522 001 Dec 31, 2007 Dec NEWA
>A> AP BAXTER HLTHCARE EQ 4MG BASE/4ML (EQ 1MG BASE/ML) N77177 001 Dec 31, 2007 Dec NEWA
>A> AP TEVA PARENTERAL EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) N78392 001 Dec 31, 2007 Dec NEWA
>A> AP EQ 1MG BASE/ML (EQ 1MG BASE/ML) N77963 001 Jan 03, 2008 Dec NEWA
>A> AP WATSON LABS EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) N78262 001 Dec 31, 2007 Dec NEWA
>A> GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE
>A> AP TEVA PARENTERAL EQ 1MG BASE/ML (EQ 1MG BASE/ML) N77165 001 Dec 31, 2007 Dec NEWA
KYTRIL
>D> + ROCHE EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) N20239 003 Sep 17, 2004 Dec CFTG
>A> AP + EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) N20239 003 Sep 17, 2004 Dec CFTG
>D> + EQ 1MG BASE/ML (EQ 1MG BASE/ML) N20239 004 Mar 11, 1994 Dec CFTG
>A> AP + EQ 1MG BASE/ML (EQ 1MG BASE/ML) N20239 004 Mar 11, 1994 Dec CFTG
>D> + EQ 4MG BASE/4ML (EQ 1MG BASE/ML) N20239 002 Mar 11, 1994 Dec CFTG
>A> AP + EQ 4MG BASE/4ML (EQ 1MG BASE/ML) N20239 002 Mar 11, 1994 Dec CFTG
TABLET; ORAL
>A> GRANISETRON HYDROCHLORIDE
>A> AB BARR EQ 1MG BASE N78221 001 Dec 31, 2007 Dec NEWA
>A> AB COREPHARMA EQ 1MG BASE N78260 001 Dec 31, 2007 Dec NEWA
>A> AB ROXANE EQ 1MG BASE N77842 001 Dec 31, 2007 Dec NEWA
>A> AB TEVA PHARMS EQ 1MG BASE N78080 001 Dec 31, 2007 Dec NEWA
KYTRIL
>D> + ROCHE EQ 1MG BASE N20305 001 Mar 16, 1995 Dec CFTG
>A> AB + EQ 1MG BASE N20305 001 Mar 16, 1995 Dec CFTG
HEPARIN SODIUM
INJECTABLE; INJECTION
HEPARIN SODIUM
>D> @ ABRAXIS PHARM 1,000 UNITS/ML N17651 005 Dec CAHN
>D> AP 1,000 UNITS/ML N17029 001 Dec CAHN
>D> AP 5,000 UNITS/ML N17651 006 Dec CAHN
>D> @ 5,000 UNITS/ML N17029 002 Dec CAHN
>D> @ 10,000 UNITS/ML N17651 003 Dec CAHN
>D> AP 10,000 UNITS/ML N17029 003 Dec CAHN
>D> @ 20,000 UNITS/ML N17651 008 Dec CAHN
>D> AP + 20,000 UNITS/ML N17029 004 Dec CAHN
>A> @ APP PHARMS 1,000 UNITS/ML N17651 005 Dec CAHN
>A> AP 1,000 UNITS/ML N17029 001 Dec CAHN
>A> AP 5,000 UNITS/ML N17651 006 Dec CAHN
>A> @ 5,000 UNITS/ML N17029 002 Dec CAHN
>A> @ 10,000 UNITS/ML N17651 003 Dec CAHN
>A> AP 10,000 UNITS/ML N17029 003 Dec CAHN
>A> @ 20,000 UNITS/ML N17651 008 Dec CAHN
>A> AP + 20,000 UNITS/ML N17029 004 Dec CAHN
>D> AP + BAXTER HLTHCARE 5,000 UNITS/0.5ML N17037 013 Apr 07, 1986 Dec DISC
>A> @ 5,000 UNITS/0.5ML N17037 013 Apr 07, 1986 Dec DISC
HEPARIN SODIUM IN PLASTIC CONTAINER
>D> AP ABRAXIS PHARM 1,000 UNITS/ML N17029 013 Dec 05, 1985 Dec CAHN
>D> AP 5,000 UNITS/ML N17029 014 Dec 05, 1985 Dec CAHN
>D> AP 10,000 UNITS/ML N17029 015 Dec 05, 1985 Dec CAHN
>D> AP 20,000 UNITS/ML N17029 016 Dec 05, 1985 Dec CAHN
>A> AP APP PHARMS 1,000 UNITS/ML N17029 013 Dec 05, 1985 Dec CAHN
>A> AP 5,000 UNITS/ML N17029 014 Dec 05, 1985 Dec CAHN
>A> AP 10,000 UNITS/ML N17029 015 Dec 05, 1985 Dec CAHN
>A> AP 20,000 UNITS/ML N17029 016 Dec 05, 1985 Dec CAHN
HEPARIN SODIUM PRESERVATIVE FREE
>D> AP + ABRAXIS PHARM 1,000 UNITS/ML N17029 010 Apr 28, 1986 Dec CAHN
>A> AP + APP PHARMS 1,000 UNITS/ML N17029 010 Apr 28, 1986 Dec CAHN
IBUPROFEN; OXYCODONE HYDROCHLORIDE
TABLET; ORAL
OXYCODONE HYDROCHLORIDE AND IBUPROFEN
>A> AB ACTAVIS ELIZABETH 400MG;5MG N78769 001 Jan 04, 2008 Dec NEWA
IRINOTECAN HYDROCHLORIDE
INJECTABLE; INJECTION
CAMPTOSAR
>A> + PFIZER INC 20MG/ML N20571 001 Jun 14, 1996 Dec CAHN
>D> + PHARMACIA AND 20MG/ML N20571 001 Jun 14, 1996 Dec CAHN
ISOSORBIDE DINITRATE
TABLET; SUBLINGUAL
>D> ISORDIL
>D> AB BIOVAIL 2.5MG N12940 004 Jul 29, 1988 Dec DISC
>A> @ 2.5MG N12940 004 Jul 29, 1988 Dec DISC
>D> AB 5MG N12940 003 Jul 29, 1988 Dec DISC
>A> @ 5MG N12940 003 Jul 29, 1988 Dec DISC
>D> + 10MG N12940 005 Jul 29, 1988 Dec DISC
>A> @ 10MG N12940 005 Jul 29, 1988 Dec DISC
LABETALOL HYDROCHLORIDE
INJECTABLE; INJECTION
LABETALOL HYDROCHLORIDE
>D> AP HOSPIRA 5MG/ML N75240 001 Nov 29, 1999 Dec CRLD
>A> AP + 5MG/ML N75240 001 Nov 29, 1999 Dec CRLD
>D> AP 5MG/ML N75239 001 Nov 29, 1999 Dec CRLD
>A> AP + 5MG/ML N75239 001 Nov 29, 1999 Dec CRLD
LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
>D> CARBOCAINE W/ NEO-COBEFRIN
>D> AP + EASTMAN KODAK 0.05MG/ML;2% N12125 002 Dec DISC
>A> @ 0.05MG/ML;2% N12125 002 Dec DISC
LEVONORGESTREL
TABLET; ORAL
PLAN B
>D> + DURAMED 0.75MG N21045 001 Jul 28, 1999 Dec DISC
>A> @ 0.75MG N21045 001 Jul 28, 1999 Dec DISC
LIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
XYLOCAINE
>D> AP + ABRAXIS 0.5% N06488 008 Dec CAHN
>D> AP + 1% N06488 007 Dec CAHN
>D> AP + 1.5% N06488 010 Dec CAHN
>D> @ 2% N06488 002 Dec CAHN
>A> AP + APP PHARMS 0.5% N06488 008 Dec CAHN
>A> AP + 1% N06488 007 Dec CAHN
>A> AP + 1.5% N06488 010 Dec CAHN
>A> @ 2% N06488 002 Dec CAHN
XYLOCAINE 4% PRESERVATIVE FREE
>D> AP + ABRAXIS 4% N10417 001 Dec CAHN
>A> AP + APP PHARMS 4% N10417 001 Dec CAHN
INJECTABLE; SPINAL
XYLOCAINE 1.5% W/ DEXTROSE 7.5%
>D> @ ABRAXIS 1.5% N16297 001 Dec CAHN
>A> @ APP PHARMS 1.5% N16297 001 Dec CAHN
JELLY; TOPICAL
XYLOCAINE
>D> AT + ABRAXIS 2% N08816 001 Dec CAHN
>A> AT + APP PHARMS 2% N08816 001 Dec CAHN
SOLUTION; ORAL
XYLOCAINE VISCOUS
>D> AT + ABRAXIS 2% N09470 001 Dec CAHN
>A> AT + APP PHARMS 2% N09470 001 Dec CAHN
SOLUTION; TOPICAL
XYLOCAINE 4% PRESERVATIVE FREE
>D> AT + ABRAXIS 4% N10417 002 Dec CAHN
>A> AT + APP PHARMS 4% N10417 002 Dec CAHN
LIDOCAINE; PRILOCAINE
CREAM; TOPICAL
EMLA
>D> AB + ABRAXIS 2.5%;2.5% N19941 001 Dec 30, 1992 Dec CAHN
>A> AB + APP PHARMS 2.5%;2.5% N19941 001 Dec 30, 1992 Dec CAHN
LISDEXAMFETAMINE DIMESYLATE
CAPSULE; ORAL
VYVANSE
>A> NEW RIVER PHARMS 20MG N21977 004 Dec 10, 2007 Dec NEWA
>A> 30MG N21977 001 Feb 23, 2007 Dec CAHN
>A> 40MG N21977 005 Dec 10, 2007 Dec NEWA
>A> 50MG N21977 002 Feb 23, 2007 Dec CAHN
>A> 60MG N21977 006 Dec 10, 2007 Dec NEWA
>A> + 70MG N21977 003 Feb 23, 2007 Dec CAHN
>D> SHIRE 30MG N21977 001 Feb 23, 2007 Dec CAHN
>D> 50MG N21977 002 Feb 23, 2007 Dec CAHN
>D> + 70MG N21977 003 Feb 23, 2007 Dec CAHN
MEPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
CARBOCAINE
>D> AP + EASTMAN KODAK 3% N12125 003 Dec DISC
>A> @ 3% N12125 003 Dec DISC
ISOCAINE HYDROCHLORIDE
>D> AP NOVOCOL 3% N80925 001 Dec CRLD
>A> AP + 3% N80925 001 Dec CRLD
SCANDONEST PLAIN
>D> AP DEPROCO 3% N88387 001 Oct 10, 1984 Dec CRLD
>A> AP + 3% N88387 001 Oct 10, 1984 Dec CRLD
METFORMIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
METFORMIN HYDROCHLORIDE
>A> AB INTERPHARM 500MG N78596 001 Jan 03, 2008 Dec NEWA
>A> AB 750MG N78596 002 Jan 03, 2008 Dec NEWA
METHIMAZOLE
TABLET; ORAL
METHIMAZOLE
>A> AB ACTAVIS TOTOWA 5MG N40734 001 Dec 14, 2007 Dec NEWA
>A> AB 10MG N40734 002 Dec 14, 2007 Dec NEWA
METRONIDAZOLE
CREAM; TOPICAL
METRONIDAZOLE
>A> AB G AND W LABS 0.75% N77549 001 Dec 19, 2007 Dec NEWA
MINOCYCLINE HYDROCHLORIDE
TABLET; ORAL
MINOCYCLINE HYDROCHLORIDE
>A> AB INDICUS PHARMA EQ 50MG BASE N65436 001 Dec 26, 2007 Dec NEWA
>A> AB EQ 75MG BASE N65436 002 Dec 26, 2007 Dec NEWA
>A> AB EQ 100MG BASE N65436 003 Dec 26, 2007 Dec NEWA
>A> NEBIVOLOL HYDROCHLORIDE
>A> TABLET; ORAL
>A> BYSTOLIC
>A> MYLAN BERTEK EQ 2.5MG BASE N21742 002 Dec 17, 2007 Dec NEWA
>A> EQ 5MG BASE N21742 003 Dec 17, 2007 Dec NEWA
>A> + EQ 10MG BASE N21742 004 Dec 17, 2007 Dec NEWA
NYSTATIN
CREAM; TOPICAL
MYCOSTATIN
>A> AT + BRISTOL MYERS 100,000 UNITS/GM N60575 001 Dec CAHN
>D> AT + RANBAXY 100,000 UNITS/GM N60575 001 Dec CAHN
POWDER; TOPICAL
MYCOSTATIN
>A> AT + BRISTOL MYERS 100,000 UNITS/GM N60578 001 Dec CAHN
>D> AT + RANBAXY 100,000 UNITS/GM N60578 001 Dec CAHN
TABLET; ORAL
>D> MYCOSTATIN
>D> AA + APOTHECON 500,000 UNITS N60574 001 Dec DISC
>A> @ BRISTOL MYERS 500,000 UNITS N60574 001 Dec DISC
OCTREOTIDE ACETATE
INJECTABLE; INJECTION
OCTREOTIDE ACETATE (PRESERVATIVE FREE)
>D> AP BEDFORD EQ 0.05MG BASE/ML N76313 001 Mar 28, 2005 Dec CRLD
>A> AP + EQ 0.05MG BASE/ML N76313 001 Mar 28, 2005 Dec CRLD
>D> AP EQ 0.1MG BASE/ML N76313 003 Mar 28, 2005 Dec CRLD
>A> AP + EQ 0.1MG BASE/ML N76313 003 Mar 28, 2005 Dec CRLD
>D> AP EQ 0.5MG BASE/ML N76313 002 Mar 28, 2005 Dec CRLD
>A> AP + EQ 0.5MG BASE/ML N76313 002 Mar 28, 2005 Dec CRLD
OXCARBAZEPINE
TABLET; ORAL
OXCARBAZEPINE
>A> AB BRECKENRIDGE 150MG N78069 001 Jan 11, 2008 Dec NEWA
>A> AB 300MG N78069 002 Jan 11, 2008 Dec NEWA
>A> AB 600MG N78069 003 Jan 11, 2008 Dec NEWA
>A> AB TEVA PHARMS 150MG N78005 001 Dec 11, 2007 Dec NEWA
>A> AB 300MG N78005 002 Dec 11, 2007 Dec NEWA
>A> AB 600MG N78005 003 Dec 11, 2007 Dec NEWA
OXYTOCIN
INJECTABLE; INJECTION
OXYTOCIN
>D> AP + ABRAXIS PHARM 10USP UNITS/ML (10USP UNITS/ML) N18248 001 Dec CAHN
>D> + 100USP UNITS/10 ML (10USP UNITS/ML) N18248 002 Dec CAHN
>D> + 300USP UNITS/30 ML (10USP UNITS/ML) N18248 003 Jul 27, 2007 Dec CAHN
>A> AP + APP PHARMS 10USP UNITS/ML (10USP UNITS/ML) N18248 001 Dec CAHN
>A> + 100USP UNITS/10 ML (10USP UNITS/ML) N18248 002 Dec CAHN
>A> + 300USP UNITS/30 ML (10USP UNITS/ML) N18248 003 Jul 27, 2007 Dec CAHN
>D> @ BAXTER HLTHCARE 10USP UNITS/ML N18243 001 Dec CMFD
>A> AP + 10USP UNITS/ML (10USP UNITS/ML) N18243 001 Dec CMFD
PACLITAXEL
INJECTABLE; INJECTION
PACLITAXEL
>A> AP EBEWE PHARMA 6MG/ML N78167 001 Dec 26, 2007 Dec NEWA
PAROMOMYCIN SULFATE
CAPSULE; ORAL
PAROMOMYCIN SULFATE
>A> AA X-GEN PHARMS EQ 250MG BASE N65173 001 Dec 14, 2007 Dec NEWA
PENTAMIDINE ISETHIONATE
FOR SOLUTION; INHALATION
NEBUPENT
>D> + ABRAXIS PHARM 300MG/VIAL N19887 001 Jun 15, 1989 Dec CAHN
>D> 600MG/VIAL N19887 002 Mar 22, 1996 Dec CAHN
>A> + APP PHARMS 300MG/VIAL N19887 001 Jun 15, 1989 Dec CAHN
>A> 600MG/VIAL N19887 002 Mar 22, 1996 Dec CAHN
INJECTABLE; INJECTION
PENTAM
>D> AP + ABRAXIS PHARM 300MG/VIAL N19264 001 Oct 16, 1984 Dec CAHN
>A> AP + APP PHARMS 300MG/VIAL N19264 001 Oct 16, 1984 Dec CAHN
PHENTERMINE HYDROCHLORIDE
CAPSULE; ORAL
PHENTERMINE HYDROCHLORIDE
>D> @ LANNETT 30MG N87022 001 Feb 03, 1983 Dec CMFD
>A> AA 30MG N87022 001 Feb 03, 1983 Dec CMFD
PHENYTOIN SODIUM
CAPSULE; ORAL
DILANTIN
>D> + PARKE DAVIS 30MG EXTENDED N84349 001 Dec CTEC
>A> AB + 30MG EXTENDED N84349 001 Dec CTEC
EXTENDED PHENYTOIN SODIUM
>A> AB WOCKHARDT 30MG EXTENDED N40759 001 Dec 18, 2007 Dec NEWA
POLYMYXIN B SULFATE
INJECTABLE; INJECTION
POLYMXIN B SULFATE
>A> AP ABRAXIS PHARM EQ 500,000 U BASE/VIAL N65372 001 Jan 10, 2008 Dec NEWA
PRAVASTATIN SODIUM
TABLET; ORAL
PRAVASTATIN SODIUM
>A> AB APOTEX 80MG N76341 004 Dec 28, 2007 Dec NEWA
>D> AB COBALT 10MG N76939 004 Oct 23, 2006 Dec CAHN
>D> AB 20MG N76939 003 Oct 23, 2006 Dec CAHN
>D> AB 40MG N76939 002 Oct 23, 2006 Dec CAHN
>A> AB COBALT LABS INC 10MG N76939 004 Oct 23, 2006 Dec CAHN
>A> AB 20MG N76939 003 Oct 23, 2006 Dec CAHN
>A> AB 40MG N76939 002 Oct 23, 2006 Dec CAHN
>A> AB 80MG N76939 001 Dec 28, 2007 Dec NEWA
>A> AB DR REDDYS LABS INC 80MG N76714 004 Dec 28, 2007 Dec NEWA
>A> AB GENPHARM 80MG N77013 004 Dec 28, 2007 Dec NEWA
>A> AB GLENMARK PHARMS 80MG N77987 004 Dec 28, 2007 Dec NEWA
>A> AB LUPIN PHARMS 10MG N77917 001 Jan 08, 2008 Dec NEWA
>A> AB 20MG N77917 002 Jan 08, 2008 Dec NEWA
>A> AB 40MG N77917 003 Jan 08, 2008 Dec NEWA
>A> AB 80MG N77917 004 Jan 08, 2008 Dec NEWA
PROPRANOLOL HYDROCHLORIDE
TABLET; ORAL
PROPRANOLOL HYDROCHLORIDE
>A> AB NORTHSTAR 10MG N78213 001 Jan 10, 2008 Dec NEWA
>A> AB 20MG N78213 002 Jan 10, 2008 Dec NEWA
>A> AB 40MG N78213 003 Jan 10, 2008 Dec NEWA
>A> AB 60MG N78213 004 Jan 10, 2008 Dec NEWA
>A> AB 80MG N78213 005 Jan 10, 2008 Dec NEWA
RAMIPRIL
CAPSULE; ORAL
ALTACE
>D> KING PHARMS 1.25MG N19901 001 Jan 28, 1991 Dec CTEC
>A> AB 1.25MG N19901 001 Jan 28, 1991 Dec CTEC
>D> 2.5MG N19901 002 Jan 28, 1991 Dec CTEC
>A> AB 2.5MG N19901 002 Jan 28, 1991 Dec CTEC
>D> 5MG N19901 003 Jan 28, 1991 Dec CTEC
>A> AB 5MG N19901 003 Jan 28, 1991 Dec CTEC
>D> + 10MG N19901 004 Jan 28, 1991 Dec CTEC
>A> AB + 10MG N19901 004 Jan 28, 1991 Dec CTEC
RAMIPRIL
>D> @ COBALT 1.25MG N76549 001 Oct 24, 2005 Dec CMFD
>A> AB 1.25MG N76549 001 Oct 24, 2005 Dec CMFD
>D> @ 2.5MG N76549 002 Oct 24, 2005 Dec CMFD
>A> AB 2.5MG N76549 002 Oct 24, 2005 Dec CMFD
>D> @ 5MG N76549 003 Oct 24, 2005 Dec CMFD
>A> AB 5MG N76549 003 Oct 24, 2005 Dec CMFD
>D> @ 10MG N76549 004 Oct 24, 2005 Dec CMFD
>A> AB 10MG N76549 004 Oct 24, 2005 Dec CMFD
RANITIDINE HYDROCHLORIDE
SYRUP; ORAL
RANITIDINE HYDROCHLORIDE
>A> AA RANBAXY EQ 15MG BASE/ML N78448 001 Dec 13, 2007 Dec NEWA
RIVASTIGMINE TARTRATE
CAPSULE; ORAL
RIVASTIGMINE TARTRATE
>A> AB WATSON LABS EQ 1.5MG BASE N77129 001 Jan 08, 2008 Dec NEWA
>A> AB EQ 3MG BASE N77129 002 Jan 08, 2008 Dec NEWA
>A> AB EQ 4.5MG BASE N77129 003 Jan 08, 2008 Dec NEWA
>A> AB EQ 6MG BASE N77129 004 Jan 08, 2008 Dec NEWA
>A> SAPROPTERIN DIHYDROCHLORIDE
>A> TABLET; ORAL
>A> KUVAN
>A> + BIOMARIN PHARM 100MG N22181 001 Dec 13, 2007 Dec NEWA
SERTRALINE HYDROCHLORIDE
TABLET; ORAL
SERTRALINE HYDROCHLORIDE
>A> AB WOCKHARDT EQ 25MG BASE N78403 001 Jan 08, 2008 Dec NEWA
>A> AB EQ 50MG BASE N78403 002 Jan 08, 2008 Dec NEWA
>A> AB EQ 100MG BASE N78403 003 Jan 08, 2008 Dec NEWA
TERBUTALINE SULFATE
INJECTABLE; INJECTION
TERBUTALINE SULFATE
>A> AP AKORN 1MG/ML N78151 001 Jan 07, 2008 Dec NEWA
TIROFIBAN HYDROCHLORIDE
INJECTABLE; INJECTION
AGGRASTAT
>A> MEDICURE EQ 5MG BASE/100ML (EQ 0.05MG N20913 002 May 17, 2002 Dec NEWA
>A> + EQ 12.5MG BASE/250ML (EQ 0.05MG N20913 003 Apr 20, 2000 Dec NEWA
>D> + EQ 0.25MG BASE/ML N20912 001 May 14, 1998 Dec CPOT
>A> + EQ 12.5MG BASE/50ML (EQ 0.25MG N20912 001 May 14, 1998 Dec CPOT
>D> + EQ 0.05MG BASE/ML N20913 001 May 14, 1998 Dec DISC
>A> @ EQ 25MG BASE/500ML (EQ 0.05MG N20913 001 May 14, 1998 Dec DISC
TIZANIDINE HYDROCHLORIDE
TABLET; ORAL
ZANAFLEX
>D> AB ACORDA EQ 2MG BASE N20397 002 Feb 04, 2000 Dec DISC
>A> @ EQ 2MG BASE N20397 002 Feb 04, 2000 Dec DISC
TOBRAMYCIN SULFATE
INJECTABLE; INJECTION
TOBRAMYCIN
>D> ABRAXIS PHARM EQ 1.2GM BASE/VIAL N50789 001 Jul 13, 2004 Dec CAHN
>A> APP PHARMS EQ 1.2GM BASE/VIAL N50789 001 Jul 13, 2004 Dec CAHN
ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST
CETIRIZINE HYDROCHLORIDE
TABLET; ORAL
CETIRIZINE HYDROCHLORIDE
>A> CARACO 5MG N77631 001 Jan 11, 2008 Dec NEWA
>A> 10MG N77631 002 Jan 11, 2008 Dec NEWA
CETIRIZINE HYDROCHLORIDE ALLERGY
>A> ACTAVIS ELIZABETH 5MG N78615 003 Dec 28, 2007 Dec NEWA
>A> 10MG N78615 004 Dec 28, 2007 Dec NEWA
>A> APOTEX INC 5MG N78317 001 Dec 27, 2007 Dec NEWA
>A> 10MG N78317 002 Dec 27, 2007 Dec NEWA
>A> CARACO 5MG N77499 001 Dec 27, 2007 Dec NEWA
>A> 10MG N77499 002 Dec 27, 2007 Dec NEWA
>A> MYLAN 5MG N76677 001 Dec 27, 2007 Dec NEWA
>A> 10MG N76677 002 Dec 27, 2007 Dec NEWA
>A> PAR PHARM 5MG N76047 001 Dec 27, 2007 Dec NEWA
>A> 10MG N76047 002 Dec 27, 2007 Dec NEWA
>A> PERRIGO R AND D 5MG N78336 001 Dec 27, 2007 Dec NEWA
>A> 10MG N78336 002 Dec 27, 2007 Dec NEWA
>A> RANBAXY 5MG N77498 001 Dec 27, 2007 Dec NEWA
>A> 10MG N77498 002 Dec 27, 2007 Dec NEWA
>A> SANDOZ 5MG N77946 001 Dec 27, 2007 Dec NEWA
>A> 10MG N77946 002 Dec 27, 2007 Dec NEWA
>A> WOCKHARDT 5MG N78427 003 Dec 28, 2007 Dec NEWA
>A> 10MG N78427 004 Dec 28, 2007 Dec NEWA
CETIRIZINE HYDROCHLORIDE HIVES
>A> ACTAVIS ELIZABETH 5MG N78615 001 Dec 28, 2007 Dec NEWA
>A> 10MG N78615 002 Dec 28, 2007 Dec NEWA
>A> APOTEX INC 5MG N78317 003 Dec 27, 2007 Dec NEWA
>A> 10MG N78317 004 Dec 27, 2007 Dec NEWA
>A> CARACO 5MG N77499 003 Dec 27, 2007 Dec NEWA
>A> 10MG N77499 004 Dec 27, 2007 Dec NEWA
>A> MYLAN 5MG N76677 004 Dec 27, 2007 Dec NEWA
>A> 10MG N76677 003 Dec 27, 2007 Dec NEWA
>A> PAR PHARM 5MG N76047 003 Dec 27, 2007 Dec NEWA
>A> 10MG N76047 004 Dec 27, 2007 Dec NEWA
>A> PERRIGO R AND D 5MG N78336 003 Dec 27, 2007 Dec NEWA
>A> 10MG N78336 004 Dec 27, 2007 Dec NEWA
>A> RANBAXY 5MG N77498 003 Dec 27, 2007 Dec NEWA
>A> 10MG N77498 004 Dec 27, 2007 Dec NEWA
>A> SANDOZ 5MG N77946 003 Dec 27, 2007 Dec NEWA
>A> 10MG N77946 004 Dec 27, 2007 Dec NEWA
>A> WOCKHARDT 5MG N78427 001 Dec 28, 2007 Dec NEWA
>A> 10MG N78427 002 Dec 28, 2007 Dec NEWA
FAMOTIDINE
TABLET, CHEWABLE; ORAL
PEPCID AC
>A> MERCK 20MG N20801 002 Dec 17, 2007 Dec NEWA
>A> OMEPRAZOLE
>A> TABLET, DELAYED RELEASE; ORAL
>A> OMEPRAZOLE
>A> + DEXCEL PHARMA 20MG N22032 001 Dec 04, 2007 Dec NEWA
Date created: January 11, 2008 |
|
|
||||||
 | ||||||
|
||||||